2025 Key events. Major US/EU approvals and submissions and phase 2/3 clinical data presentations being planned or achieved for the year. Learn more

Jan 22, 2025 · NEW BRUNSWICK, N.J.--(BUSINESS WIRE)-- Johnson & Johnson (NYSE: JNJ) today announced results for fourth-quarter and full year 2024. "2024 was a transformative year …

1 day ago · Johnson & Johnson MedTech innovates at the intersection of biology and technology. With a focus on treating with pinpoint precision in the hardest-to-reach parts of the body, …

See all of Johnson & Johnson's global website links

Get in touch with Johnson & Johnson . You are now leaving jnj.com. The site you’re being redirected to is a branded pharmaceutical website.

Be, feel and do your best. The flexible employee benefits we offer at Johnson & Johnson reflect Our Credo values and are a way to create a truly inclusive place where you belong. When …

Johnson & Johnson MedTech innovates at the intersection of biology and technology. With a focus on treating with pinpoint precision in the hardest-to-reach parts of the body, restoring …

At Johnson & Johnson, we believe health is everything. Our strength in healthcare innovation empowers us to build a world where complex diseases are prevented, treated and cured, …

• 2025 First-Quarter reported sales growth of 2.4% to $21.9 Billion with operational growth of 4.2%* and adjusted operational growth of 3.3%* • 2025 First-Quarter earnings per share (EPS) …

Elevate your career with J&J. Discover global job opportunities to drive innovation, impact lives and grow in a supportive, mission-driven culture.